Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 9:2014:276260.
doi: 10.1155/2014/276260. eCollection 2014.

Carrier-based drug delivery system for treatment of acne

Amber Vyas  1 , Avinesh Kumar Sonker  1 , Bina Gidwani  1
Affiliations
Review

Carrier-based drug delivery system for treatment of acne

Amber Vyas et al. ScientificWorldJournal. .

Abstract

Approximately 95% of the population suffers at some point in their lifetime from acne vulgaris. Acne is a multifactorial disease of the pilosebaceous unit. This inflammatory skin disorder is most common in adolescents but also affects neonates, prepubescent children, and adults. Topical conventional systems are associated with various side effects. Novel drug delivery systems have been used to reduce the side effect of drugs commonly used in the topical treatment of acne. Topical treatment of acne with active pharmaceutical ingredients (API) makes direct contact with the target site before entering the systemic circulation which reduces the systemic side effect of the parenteral or oral administration of drug. The objective of the present review is to discuss the conventional delivery systems available for acne, their drawbacks, and limitations. The advantages, disadvantages, and outcome of using various carrier-based delivery systems like liposomes, niosomes, solid lipid nanoparticles, and so forth, are explained. This paper emphasizes approaches to overcome the drawbacks and limitations associated with the conventional system and the advances and application that are poised to further enhance the efficacy of topical acne formulations, offering the possibility of simplified dosing regimen that may improve treatment outcomes using novel delivery system.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Difference between normal skin and skin with acne.
Figure 2
Figure 2
Future forecast of acne.
Figure 3
Figure 3
Treatment strategies used for acne.
Figure 4
Figure 4
Novel carrier-based drug delivery system for treatment of acne.
See this image and copyright information in PMC

References

    1. Ho V, Schacter D, Miller R. Acne management for the 90s: current treatment guidelines. The Canadian Journal of Diagnosis. 1995;12:1–25.
    1. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clinical Biochemistry. 2011;44(13):1035–1040. - PubMed
    1. Falcocchio S, Ruiz C, Pastor FIJ, Saso L, Diaz P. Propionibacterium acnes GehA lipase, an enzyme involved in acne development, can be successfully inhibited by defined natural substances. Journal of Molecular Catalysis B. 2006;40(3-4):132–137.
    1. Bloom DF. Is acne really a disease? A theory of acne as an evolutionarily significant, high-order psychoneuroimmune interaction timed to cortical development with a crucial role in mate choice. Medical Hypotheses. 2004;62(3):462–469. - PubMed
    1. Lucky AW, Cullen SI, Funicella T, Jarratt MT, Jones T, Reddick ME. Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris. Journal of the American Academy of Dermatology. 1998;38(4):S24–S30. - PubMed

Publication types

MeSH terms